Vistara Bioscience

Vistara Bioscience is a private U.S. biotechnology company developing proteomics and informatics platforms to support biomarker discovery, target identification, and drug candidate profiling. The company appears to focus especially on targeted protein degradation and broader proteostasis biology, using mass spectrometry-based and ubiquitomics-enabled workflows to map protein interaction networks and context-dependent biology. Rather than operating as a traditional clinical-stage therapeutics company with disclosed drug assets, Vistara seems to position itself as a platform-driven discovery company serving pharma and biotech research needs. Its stated disease interests include oncology, inflammation, and neurodegeneration, including Parkinson's disease. Publicly available information suggests the company remains small, private, and early stage, with limited disclosed pipeline details.